Ostojic Ana, Petrovic Igor, Silovski Hrvoje, Kosuta Iva, Sremac Maja, Mrzljak Anna
Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb 10000, Croatia.
Department of Hepatobiliary Surgery and Transplantation, University Hospital Center Zagreb, Zagreb 10000, Croatia.
World J Hepatol. 2022 Sep 27;14(9):1739-1746. doi: 10.4254/wjh.v14.i9.1739.
Persistent ascites (PA) after liver transplantation (LT), commonly defined as ascites lasting more than 4 wk after LT, can be expected in up to 7% of patients. Despite being relatively rare, it is associated with worse clinical outcomes, including higher 1-year mortality. The cause of PA can be divided into vascular, hepatic, or extrahepatic. Vascular causes of PA include hepatic outflow and inflow obstructions, which are usually successfully treated. Regarding modifiable hepatic causes, recurrent hepatitis C and acute cellular rejection are the leading ones. Considering predictors for PA, the presence of ascites, refractory ascites, hepato-renal syndrome type 1, spontaneous bacterial peritonitis, hepatic encephalopathy, and prolonged ischemic time significantly influence the development of PA after LT. The initial approach to patients with PA should be to diagnose the treatable cause of PA. The stepwise approach in evaluating PA includes diagnostic paracentesis, ultrasound with Doppler, and an echocardiogram when a cardiac cause is suspected. Finally, a percutaneous or transjugular liver biopsy should be performed in cases where the diagnosis is unclear. PA of unknown cause should be treated with diuretics and paracentesis, while transjugular intrahepatic portosystemic shunt and splenic artery embolization are treatment methods in patients with refractory ascites after LT.
肝移植(LT)后持续性腹水(PA),通常定义为LT后腹水持续超过4周,在高达7%的患者中可能出现。尽管相对少见,但它与更差的临床结局相关,包括更高的1年死亡率。PA的病因可分为血管性、肝脏性或肝外性。PA的血管性病因包括肝流出道和流入道梗阻,这些通常可得到成功治疗。关于可改变的肝脏性病因,丙型肝炎复发和急性细胞排斥是主要原因。考虑到PA的预测因素,腹水、难治性腹水、1型肝肾综合征、自发性细菌性腹膜炎、肝性脑病以及较长的缺血时间会显著影响LT后PA的发生。对PA患者的初始处理应是诊断PA的可治疗病因。评估PA的逐步方法包括诊断性腹腔穿刺、多普勒超声检查,以及怀疑心脏病因时进行超声心动图检查。最后,在诊断不明确的情况下应进行经皮或经颈静脉肝活检。病因不明的PA应采用利尿剂和腹腔穿刺治疗,而经颈静脉肝内门体分流术和脾动脉栓塞术是LT后难治性腹水患者的治疗方法。